Quanying Zhang, MD, PhD

The Second Affiliated Hospital of Soochow University, China (People's Republic)

ZHANG Quanying, is currently a chief pharmacist and the director of the Drug Clinical Trial Institution at the Second Affiliated Hospital of Soochow University (the “Hospital”). She graduated from China Pharmaceutical University (formerly Nanjing Pharmaceutical College) and has been engaged in clinical research in pharmacy and new drugs at the Hospital for more than 30 years. Her current research focuses on clinical trial management and phase I cnical study of new drugs. In the past ten years, she has led over 100 drug clinical trials and has published more than sixty papers in related areas (more than ten papers were published in SCI-indexed journals). She is a member of the Drug Clinical Trial Professional Committee of Chinese Pharmacological Society, and a member of the Drug Clinical Evaluation and Research Professional Committee of Jiangsu Pharmaceutical Association.

Poster(s):

• P-206 - A RANDOMIZED PHASE 1 STUDY TO COMPARE THE PHARMACOKINETICS, SAFETY, TOLERABILITY AND IMMUNOGENICITY BETWEEN HLX02, REFERENCE US- AND EU-APPROVED TRASTUZUMAB IN HEALTHY CHINESE MALE VOLUNTEERS.